Table 5. Predictors of MACCE by Univariate and Multivariate Cox Regression Analysis.
| Variables | Univariate HR (95% CI) | P value | Multivariate HR (95% CI) | P value |
|---|---|---|---|---|
| sST2 ＞ 34.2 ng/ml | 9.76 (4.1-23.4) | ＜0.001 | 10.22 (4.05-25.7) | ＜0.001 |
| eGFR | 0.997 (0.98-1.02) | 0.747 | - | - |
| Age | 1.04 (0.992-1.08) | 0.113 | - | - |
| White blood cell | 1.1 (0.92-1.32) | 0.287 | - | - |
| Peak cTnI | 1.01 (0.95-1.06) | 0.824 | - | - |
| NT-pro BNP | 1.00 (1.00-1.001) | 0.004 | 1.00 (1.00-1.001) | 0.826 |
| Gensini | 1.004 (0.99-1.02) | 0.561 | - | - |
| No-reflow phenomenon | 0.36 (0.15-0.91) | 0.031 | 0.48 (0.17-1.33) | 0.158 |
| Diabetes mellitus | 0.35 (0.16-0.76) | 0.008 | 0.25 (0.11-0.595) | 0.002 |
| Hypertension | 0.64 (0.28-1.48) | 0.294 | - | |
| Multivessel disease | 1.78 (0.67-4.73) | 0.251 | - | |
| LVEF | 0.92 (0.87-0.98) | 0.011 | 0.96 (0.89-1.04) | 0.316 |
| Neutrophil counts | 0.87 (0.67-1.12) | 0.279 |
Abbreviations: cTnI, cardiac troponin I; NT-pro BNP, N-terminal pro-B-type natriuretic peptide; sST2: soluble suppression of tumorigenicity 2; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; HR: hazard ratio.